Skip to search formSkip to main contentSkip to account menu

IMD-0560

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
The Novel IκB Kinase β Inhibitor, IMD-0560, Has Potent Therapeutic Efficacy in Ovarian Cancer Xenograft Model Mice
Objective Aberrant activation of nuclear factor-kappa β (NF-κB) signaling has been correlated with poor outcome among patients… 
2014
2014
The novel IκB kinase β inhibitor IMD-0560 prevents bone invasion by oral squamous cell carcinoma
Oral squamous cell carcinoma (OSCC) cells display significantly augmented nuclear factor-κB (NF-κB) activity, and inhibiting this… 
2008
2008
A novel IKK inhibitor suppresses heart failure and chronic remodeling after myocardial ischemia via MMP alteration.
OBJECTIVE Amplification of inflammatory response in the non-infarct area plays an important role in the pathogenesis of… 
2008
2008
Abstract 3893: A Novel IKK Inhibitor IMD-0560: Suppresses Chronic Remodeling after Myocardial Ischemia
Highly Cited
2005
Highly Cited
2005
Effect of nuclear factor-kappaB inhibition on rheumatoid fibroblast-like synoviocytes and collagen induced arthritis.
OBJECTIVE The nuclear factor-kB (NF-kB) signaling pathway has been implicated as a molecular target for the treatment of various… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)